You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 141 No. 11, November 2006 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Review Article
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Bacterial Infections
 •Surgery
 •Surgical Interventions
 •Surgical Physiology
 •Surgical Cytokines
 •Review
 •Immunology
 •Allergy
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Cell Response to Surgery

Niamh Ni Choileain, MD; H. Paul Redmond, MCh, FRCSI

Arch Surg. 2006;141:1132-1140.

Objectives  To describe the profound alterations in host immunity that are produced by major surgery as demonstrated by experimental and clinical studies, and to evaluate the benefits of therapeutic strategies aimed at attenuating perioperative immune dysfunction.

Data Sources  A review of the English-language literature was conducted, incorporating searches of the MEDLINE, EMBASE, and Cochrane collaboration databases to identify laboratory and clinical studies investigating the cellular response to surgery.

Study Selection  Original articles and case reports describing immune dysfunction secondary to surgical trauma were included.

Data Extraction  The results were compiled to show outcomes of different studies and were compared.

Data Synthesis  Current evidence indicates that the early systemic inflammatory response syndrome observed after major surgery that is characterized by proinflammatory cytokine release, microcirculatory disturbance, and cell-mediated immune dysfunction is followed by a compensatory anti-inflammatory response syndrome, which predisposes the patient to opportunistic infection, multiple organ dysfunction syndrome, and death. Because there are currently no effective treatment options for multiple organ dysfunction syndrome, measures to prevent its onset should be initiated at an early stage. Accumulating experimental evidence suggests that targeted therapeutic strategies involving immunomodulatory agents such as interferon {gamma}, granulocyte colony-stimulating factor, the prostaglandin E2 antagonist, indomethacin, and pentoxifylline may be used for the treatment of systemic inflammatory response syndrome to prevent the onset of multiple organ dysfunction syndrome.

Conclusions  Surgical trauma produces profound immunological dysfunction. Therapeutic strategies directed at restoring immune homeostasis should aim to redress the physiological proinflammatory–anti-inflammatory cell imbalance associated with major surgery.


Author Affiliations: Department of Surgery, Cork University Hospital, Wilton, Cork, Ireland.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Immune Cell Populations Decrease During Craniotomy Under General Anesthesia
Liu et al.
Anesth. Analg. 2011;113:572-577.
ABSTRACT | FULL TEXT  

Surgery-induced reactive oxygen species enhance colon carcinoma cell binding by disrupting the liver endothelial cell lining
Gul et al.
Gut 2011;60:1076-1086.
ABSTRACT | FULL TEXT  

Delayed hemolytic transfusion reaction in children with sickle cell disease
de Montalembert et al.
haematol 2011;96:801-807.
ABSTRACT | FULL TEXT  

Systemic inflammation and fracture healing
Bastian et al.
J. Leukoc. Biol. 2011;89:669-673.
ABSTRACT | FULL TEXT  

The cellular immunological responses of patients undergoing coronary artery bypass grafting compared with those of patients undergoing valve replacement
Rudensky et al.
Eur J Cardiothorac Surg 2010;37:1056-1062.
ABSTRACT | FULL TEXT  

Anesthesia and the Microcirculation
Turek et al.
SEMIN CARDIOTHORAC VASC ANESTH 2009;13:249-258.
ABSTRACT  

The Effect of Perioperative Intravenous Lidocaine on Postoperative Pain and Immune Function
Yardeni et al.
Anesth. Analg. 2009;109:1464-1469.
ABSTRACT | FULL TEXT  

Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport
Moos et al.
FASEB J. 2008;22:4352-4362.
ABSTRACT | FULL TEXT  

Low-dose ketamine affects immune responses in humans during the early postoperative period
Beilin et al.
Br J Anaesth 2007;99:522-527.
ABSTRACT | FULL TEXT  

Neurodevelopmental Outcomes of Very Low-Birth-Weight Infants With Necrotizing Enterocolitis: A Systematic Review of Observational Studies
Schulzke et al.
Arch Pediatr Adolesc Med 2007;161:583-590.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.